RÉSUMÉ
Objective To investigate the clinical effect of Walit on central serous retinopathy. Methods A total of 92 patients with central serous retinal retinopathy were enrolled in our hospital from January 2015 to January 2017, and were randomly divided into control group and study group (n=46). The control group, the central serous chorioretinopathy treated with laser therapy, the study group by laser combined with Walit therapy, two groups were treated for 4 weeks, the curative effect and follow-up records, the data input SPSS software. Results The two groups of central serous chorioretinopathy patients successfully completed the treatment. The study group central serous chorioretinopathy in patients with clinical therapy in the treatment of the total efficiency (91.30 %) was significantly better than the control group (76.09 %), the differences were statistically significant (P<0.05); recurrence rate of study group (0.00 %) was significantly lower than the control group (13.04 %), the differences were statistically significant (P<0.05). Conclusion The use of laser treatment for central serous chorioretinopathy combined with Wolitingke significantly improve curative effect, has the positive significance to guarantee the prognosis and quality of life.
RÉSUMÉ
Objective To investigate the clinical effect of Walit on central serous retinopathy. Methods A total of 92 patients with central serous retinal retinopathy were enrolled in our hospital from January 2015 to January 2017, and were randomly divided into control group and study group (n=46). The control group, the central serous chorioretinopathy treated with laser therapy, the study group by laser combined with Walit therapy, two groups were treated for 4 weeks, the curative effect and follow-up records, the data input SPSS software. Results The two groups of central serous chorioretinopathy patients successfully completed the treatment. The study group central serous chorioretinopathy in patients with clinical therapy in the treatment of the total efficiency (91.30 %) was significantly better than the control group (76.09 %), the differences were statistically significant (P<0.05); recurrence rate of study group (0.00 %) was significantly lower than the control group (13.04 %), the differences were statistically significant (P<0.05). Conclusion The use of laser treatment for central serous chorioretinopathy combined with Wolitingke significantly improve curative effect, has the positive significance to guarantee the prognosis and quality of life.